Back to search results

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Non-small Cell Lung Cancer · Advanced Pancreatic Adenocarcinoma · Unresectable Pancreatic Cancer · Ductal Adenocarcinoma of the Pancreas

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Jonathan Leeman, MD) · jonathe_leeman@dfci.harvard.edu · 6177326452
    Contact: Principal Investigator (Jonathan Leeman, MD)

  • Dana Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Jonathan Leeman, MD) · jonathe_leeman@dfci.harvard.edu · 6177326452
    Contact: Principal Investigator (Jonathan Leeman, MD)
Study leads

  • Jonathan Leeman, MD

    Principal Investigator

    Dana-Farber Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)